Video

Colorectal Experts Discuss the ASCO Annual Meeting

In the final segment of an in-depth discussion on the treatment of colorectal cancer, which was filmed in Chicago during 2015 ASCO Annual Meeting, moderator John L. Marshall, MD, asks each panelists what they enjoy most about the annual meeting. For Fadi Braiteh, MD, the ASCO meeting provides a great opportunity to network with sponsors and other key opinion leaders.

The meeting allows participants to exchange ideas, assist in planning ongoing studies, and discuss the next steps in clinical development. The interactions and discussions at ASCO stimulate researchers and practitioners to find innovative ways to treat cancer, adds Howard S. Hochster, MD. In addition to allowing attendees to meet new oncologists, the meeting allows those who are focused on a single area to learn what advances are being made in other malignancies, comments Richard L. Goldberg, MD.

Related Videos
Haley M. Hill, PA-C, discusses preliminary data for zenocutuzumab in NRG1 fusion–positive non–small cell lung cancer and pancreatic cancer.
Haley M. Hill, PA-C, discusses how physician assistants aid in treatment planning for NRG1-positive non–small cell lung cancer and pancreatic cancer.
Haley M. Hill, PA-C, discusses DNA vs RNA sequencing for genetic testing in non–small cell lung cancer and pancreatic cancer.
Haley M. Hill, PA-C, discusses current approaches and treatment challenges in NRG1-positive non–small cell lung cancer and pancreatic cancer.
Aparna Parikh, MD
Tanios Bekaii-Saab, MD, FACP
Cindy Medina Pabon, MD, assistant professor, Sylvester Cancer Center, University of Miami; assistant lead, GI Cancer Clinical Research, Gastrointestinal Medical Oncology, University of Miami Health Systems
Aparna Parikh, MD, associate professor, medicine, Harvard Medical School; assistant in medicine, Hematology, Oncology, Massachusetts General Hospital; attending oncologist, Tucker Gosnell Center for Gastrointestinal Cancers, the Henri and Belinda Termeer Center for Targeted Therapies
Mohammed Najeeb Al Hallak, MD, MS, and Sakti Chakrabarti, MD, discuss ongoing research in gastrointestinal cancers.
Mohammed Najeeb Al Hallak, MD, MS, and Sakti Chakrabarti, MD, discuss research building upon approved combinations in unresectable hepatocellular carcinoma.